In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Therapeuticsmd Inc. (NYSEMKT:TXMD) reported that Smith Robert J has picked up 12,157,505 of common stock as of 2017-03-22.
The acquisition brings the aggregate amount owned by Smith Robert J to a total of 12,157,505 representing a 6.15% stake in the company.
For those not familiar with the company, TherapeuticsMD, Inc. is a women’s healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.
A glance at Therapeuticsmd Inc. (NYSEMKT:TXMD)’s key stats reveals a current market capitalization of 1.22 Billion based on 197.52 Million shares outstanding and a price at last close of $6.42 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-11, Collins picked up 16,000 at a purchase price of $6.23. This brings their total holding to 36,000 as of the date of the filing.
On the sell side, the most recent transaction saw Krassan unload 30,000 shares at a sale price of $8.18. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Therapeuticsmd Inc. (NYSEMKT:TXMD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.